In this article
If your clinician has prescribed progesterone alongside estrogen, it is fair to ask what it might feel like. Most of what we know about oral micronized progesterone comes from the FDA label for Prometrium, the FDA-approved capsule, and from The Menopause Society's 2022 hormone therapy position statement [1, 2]. This guide walks through the common side effects, the rare serious ones, the warning signs that mean you should call someone today, and what the evidence says about how micronized progesterone compares with synthetic progestins.
Why progesterone is part of hormone therapy
Estrogen on its own can make the lining of the uterus (the endometrium) overgrow, which raises the risk of endometrial hyperplasia and cancer [2]. That is why The Menopause Society says women who still have a uterus and use systemic estrogen should also take an adequate progestogen [2]. Progestogen is the umbrella word. It covers synthetic progestins, such as medroxyprogesterone acetate (MPA) and norethindrone acetate, and micronized progesterone, which is structurally identical to the progesterone your ovaries made [2].
The FDA label for Prometrium lists this use directly: preventing endometrial hyperplasia in postmenopausal women with a uterus who are taking estrogen [1]. MedlinePlus describes it the same way, as a capsule used along with estrogen to manage menopause symptoms [3].
On dosing, the label describes a single daily dose at bedtime on 12 days of each 28-day cycle, and the position statement gives 200 mg a day for 12 to 14 days a month as an example of adequate dosing for endometrial protection [1, 2]. Other schedules exist. Your clinician decides your dose and schedule based on your health, your estrogen dose, and how you respond.
The common side effects
The Prometrium label reports side effects from a 3-year placebo-controlled trial of 875 postmenopausal women [1]. In that trial, the progesterone group also took oral conjugated estrogens, so the numbers below reflect the combination compared with placebo. They do not isolate progesterone's effect alone [1].
| Side effect | Progesterone + estrogen | Placebo |
|---|---|---|
| Headache | 31% | 27% |
| Breast tenderness | 27% | 6% |
| Depression | 19% | 12% |
| Dizziness | 15% | 9% |
| Abdominal bloating | 12% | 5% |
| Worry | 8% | 4% |
| Breast pain | 6% | 2% |
| Swelling of hands and feet | 6% | 9% |
| Hot flashes | 11% | 35% |
A few things stand out. Breast tenderness was far more common with treatment than with placebo. Headache was common in both groups. Hot flashes were much less common with treatment, which is the point of hormone therapy for many women [1].
Drowsiness and dizziness
The label says progesterone capsules may cause temporary dizziness and drowsiness and should be taken as a single daily dose at bedtime [1]. The Menopause Society notes that oral micronized progesterone has mildly sedating effects and should therefore be taken at night [2]. Some women find this helps them fall asleep. A meta-analysis cited in the position statement found it improved how quickly women fell asleep, but not total sleep time [2].
The label also advises caution when driving or operating machinery [1]. MedlinePlus adds that you should avoid driving until you know how it affects you, and stand up slowly, especially when you first start [3].
During the first weeks, a few women have had a stronger reaction: extreme dizziness or drowsiness, blurred vision, slurred speech, trouble walking, confusion, or feeling drunk [1]. If that happens, the label says to talk with your healthcare provider right away [1].
Breast tenderness
Breast tenderness was one of the clearest differences between treatment and placebo in the label trial [1]. MedlinePlus lists breast soreness among the common side effects to mention if it is severe or does not go away [3]. Tenderness is different from a new breast lump. A lump is on the list of serious side effects to report promptly [3].
Headache
Headache is listed among the less serious, common side effects [1, 3]. A sudden, new, severe headache is different. The label lists it as a warning sign of a serious side effect [1].
Bloating and fluid retention
Abdominal bloating was reported more often with treatment than placebo in the label trial [1]. The label also notes that progesterone may cause some degree of fluid retention, and that women with heart or kidney conditions need careful observation [1]. The Menopause Society lists bloating and fluid retention among the more common adverse events of hormone therapy [2]. If you are wondering whether this means weight gain, see our article on whether HRT causes weight gain.
Mood changes
Depression and worry were both reported more often with treatment than placebo in the label trial [1]. MedlinePlus lists mood changes, irritability, and excessive worry as common side effects [3]. The Menopause Society specifically describes mood swings as progestogen related [2]. If your mood shifts in a way that worries you, or you notice it lines up with the days you take progesterone, tell your clinician. Do not stop or change your dose on your own [3].
Other side effects on the label
- Irregular vaginal bleeding or spotting [1]
- Stomach cramps, nausea, or vomiting [1]
- Hair loss [1]
- Vaginal discharge or a vaginal yeast infection [1, 3]
- Fatigue [3]
Warning signs: when to call right away
Serious side effects are less common, but they matter. The label lists abnormal blood clotting, including stroke, heart attack, and a clot in the lung, among the serious risks [1]. It names these warning signs [1]:
- Changes in vision or speech
- A sudden, new, severe headache
- Severe pain in your chest or legs, with or without shortness of breath, weakness, or fatigue
- Dizziness and faintness
- Vomiting
MedlinePlus adds sudden swelling or pain in an arm or leg, coughing up blood, facial drooping or sudden weakness or numbness, a breast lump, a migraine, and signs of an allergic reaction such as hives or swelling of the face or throat [3]. The label also says to see your healthcare provider right away for unusual vaginal bleeding [1].
Signs of a stroke, heart attack, or a clot in the lung are emergencies. Call 911 rather than waiting for a callback.
Who should not take progesterone
The Prometrium label lists these contraindications: allergy to its ingredients, including peanuts; abnormal genital bleeding without a known cause; known, suspected, or past breast cancer; active or past deep vein thrombosis or pulmonary embolism; active or past stroke or heart attack; and known liver disease [1]. The label also says it should be stopped if a clot, stroke, or heart attack occurs or is suspected, and, if feasible, at least 4 to 6 weeks before surgery linked to a higher clot risk [1].
The peanut oil note
FDA-approved Prometrium capsules contain peanut oil, and the label says they should not be used if you are allergic to peanuts [1]. If you have a peanut allergy, tell your clinician, and ask the pharmacy what oil any progesterone capsule contains, compounded or not.
MedlinePlus also asks you to tell your clinician about seizures, migraines, asthma, diabetes, depression, and liver, kidney, heart, or gallbladder disease, and about supplements such as St. John's wort [3].
Micronized progesterone vs synthetic progestins
Much of the fear around hormone therapy comes from the Women's Health Initiative (WHI). Its estrogen plus progestin arm used oral conjugated estrogens with MPA, a synthetic progestin, and reported higher risks of clots in the lung and legs, stroke, and heart attack compared with placebo [1]. The label itself notes that only that one combination was studied, so how the findings apply to other progestogens and routes is not known [1].
Breast cancer
The Menopause Society describes breast cancer with estrogen plus progestogen as a rare risk for women under 60 [2]. On the type of progestogen, it says some but not all observational data suggest micronized progesterone may have a lesser association with breast cancer than synthetic progestins such as MPA, and that randomized trials are needed to confirm this [2].
A 2016 systematic review pooled three observational studies of 86,881 postmenopausal women. It found progesterone combined with estrogen was associated with a lower breast cancer risk than synthetic progestins combined with estrogen (relative risk 0.67) [4]. The authors rated the evidence as low quality, because the studies were observational and the result leaned heavily on one large study [4]. In plain terms: a reassuring signal, not proof.
Blood clots
The position statement says micronized progesterone may be less likely to promote clots than other progestins, and that transdermal estrogen has not been linked to clot risk in observational studies [2]. It is also clear that comparative randomized trials are lacking [2]. Clinical trials have not yet been designed to tell us whether oral micronized progesterone with estrogen raises the risk of breast cancer, stroke, heart attack, or clots the way the WHI combination did [2].
The uterine lining
There is one area where micronized progesterone does not look better. With long-term use, observational studies suggest a possibly higher risk of endometrial cancer with micronized progesterone than with other progestogens, and with cyclic rather than continuous schedules [2]. This is why adequate dosing matters, and why unexpected bleeding should always be checked [1, 2].
For more on how these risks fit together, see is HRT safe? and our guide to progesterone without estrogen.
Compounded vs FDA-approved progesterone
Micronized progesterone is available as an FDA-approved product, which comes with a full label based on clinical trials [1, 2]. Compounded versions are prepared by a pharmacy from a prescription. The FDA states that compounded drugs are not FDA-approved, and that the agency does not verify their safety, effectiveness, or quality before they are sold [5].
The Menopause Society raises concerns about compounded bioidentical hormones, including limited regulation, possible over- or under-dosing, and a lack of safety and efficacy data [2]. It says compounded hormones may be considered in some situations, such as an allergy to an ingredient in an approved product or a dose that approved products do not offer [2]. Ask your clinician which option fits you and why.
Living with side effects
- Take it at bedtime, as the label directs, so any drowsiness happens while you sleep [1].
- If capsules are hard to swallow, the label suggests taking your dose with a glass of water while standing [1].
- Ask about grapefruit and grapefruit juice, and list every supplement you take [3].
- Keep up with breast exams, mammograms, and pelvic exams as your clinician recommends [1].
- Track side effects for a few cycles so you and your clinician can see patterns.
- Never stop, start, or change your dose on your own. Talk to your clinician first [3].
Getting progesterone through WarriorBabe Health
WarriorBabe Health offers oral progesterone capsules, taken nightly at bedtime, as part of a prescription hormone plan reviewed by a licensed clinician. Our capsules are compounded by a licensed pharmacy. They are not FDA-approved, and the FDA does not verify the safety, effectiveness, or quality of compounded drugs [5]. FDA-approved micronized progesterone also exists, and your clinician can talk through both [1, 2].
To see whether hormone therapy may be a fit, take the 2-minute quiz. A clinician reviews your history, including allergies, clotting risk, and breast history, before anything is prescribed. You can also browse all hormone treatments.
Frequently asked questions
What are the most common progesterone side effects?
In the main trial behind the Prometrium label, where women took progesterone with estrogen, the most common complaints were headache, breast tenderness, depression, dizziness, and abdominal bloating. Breast tenderness showed the biggest gap versus placebo. Hot flashes were much less common on treatment. These figures reflect the combination, not progesterone alone [1].
Why do I have to take progesterone at bedtime?
Oral progesterone can cause temporary drowsiness and dizziness, so the FDA label says to take it as a single dose at bedtime and to use caution when driving [1]. The Menopause Society describes it as mildly sedating and recommends nighttime dosing [2]. Some women find it helps them fall asleep faster [2].
Can I take progesterone if I'm allergic to peanuts?
FDA-approved Prometrium contains peanut oil, and its label says not to use it if you are allergic to peanuts [1]. Other capsules, including compounded ones, have their own ingredient lists, so do not assume either way. Tell your clinician about any peanut allergy and confirm the capsule's ingredients with the pharmacy before you take it.
Is micronized progesterone safer than synthetic progestins?
It may be, but the evidence is not settled. Observational studies suggest micronized progesterone may have a lesser association with breast cancer and clots than synthetic progestins such as MPA [2, 4]. A 2016 review rated that evidence low quality [4], and The Menopause Society says randomized trials are needed [2]. Your clinician can weigh this for your history.
When should I call a doctor about progesterone side effects?
Call right away for vision or speech changes, a sudden severe headache, chest or leg pain, shortness of breath, faintness, or unusual vaginal bleeding [1]. Sudden arm or leg swelling, a breast lump, or signs of an allergic reaction also need prompt attention [3]. Signs of a stroke, heart attack, or lung clot are emergencies, so call 911.
References
- Prometrium (progesterone, USP) capsules prescribing information. U.S. Food and Drug Administration; revised 02/2026. www.accessdata.fda.gov/drugsatfda_docs/label/2026/019781s026lbl.pdf
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. menopause.org/wp-content/uploads/professional/nams-2022-hormone-therapy-position-statement.pdf
- Progesterone. MedlinePlus Drug Information. U.S. National Library of Medicine; revised 2026. medlineplus.gov/druginfo/meds/a604017.html
- Asi N, Mohammed K, Haydour Q, et al. Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis. Syst Rev. 2016;5:121. pmc.ncbi.nlm.nih.gov/articles/PMC4960754/
- Compounding and the FDA: Questions and Answers. U.S. Food and Drug Administration. www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
This article is for general information. It is not medical advice and does not replace a visit with a licensed clinician who knows your history. Do not start, stop or change a medication without talking to your clinician. If you think you are having a medical emergency, call 911.
